Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 3/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 3/20 | 1.00 |
| ▸ | MEN1 | O00255 | 2/20 | 0.93 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.93 |
| ▸ | GLA | P06280 | 1/20 | 0.93 |
| ▸ | KDM1A | O60341 | 5/20 | 0.65 |
| ▸ | TSHR | P16473 | 3/20 | 0.65 |
| ▸ | SAT1 | P21673 | 3/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.59 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | CA12 | O43570 | 3/20 | 0.44 |
| ▸ | CA2 | P00918 | 3/20 | 0.44 |
| ▸ | CA4 | P22748 | 3/20 | 0.44 |
| ▸ | CA6 | P23280 | 3/20 | 0.44 |
| ▸ | CA5A | P35218 | 3/20 | 0.44 |
| ▸ | CA7 | P43166 | 3/20 | 0.44 |
| ▸ | CA9 | Q16790 | 3/20 | 0.44 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.44 |
| ▸ | CA5B | Q9Y2D0 | 3/20 | 0.44 |
| ▸ | CA3 | P07451 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6899291 | 1.00 | CYP2C19 (1.00) | CYP2C19CYP1A2MEN1KMT2AGLA | |
| SCHEMBL7871599 | 1.00 | CYP2C19 (1.00) | CYP2C19CYP1A2MEN1KMT2AGLA | |
| SCHEMBL4157457 | 1.00 | CYP2C19 (1.00) | CYP2C19CYP1A2MEN1KMT2AGLA | |
| SCHEMBL4171429 | 1.00 | CYP2C19 (1.00) | CYP2C19CYP1A2MEN1KMT2AGLA | |
| SCHEMBL10045117 | 1.00 | CYP2C19 (1.00) | CYP2C19CYP1A2MEN1KMT2AGLA | |
| SCHEMBL4167237 | 1.00 | CYP2C19 (1.00) | CYP2C19CYP1A2MEN1KMT2AGLA | |
| SCHEMBL2529872 | 0.97 | CYP2C19 (0.93) | CYP2C19CYP1A2MEN1KMT2AGLA | |
| SCHEMBL10045203 | 0.97 | CYP2C19 (0.93) | CYP2C19CYP1A2MEN1KMT2AGLA | |
| Bis(Ethyl)Spermine SCHEMBL8526460 | 0.97 | CYP2C19 (0.93) | CYP2C19CYP1A2MEN1KMT2AGLA | |
| SCHEMBL10045209 | 0.97 | CYP2C19 (0.93) | CYP2C19CYP1A2MEN1KMT2AGLA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-8217670-A | — | — | None | — | — | JP | disclosed |
| US-20250270572-A1 | GENE EXPRESSION ELEMENTS AND SYSTEMS AND USE THEREOF | GENENEER LTD. (IL) | 2025-08-28 | — | — | US | disclosed |
| US-12297438-B2 | Gene expression elements and systems and use thereof | GENENEER LTD. (IL) | 2025-05-13 | — | — | US | disclosed |
| US-20250140406-A1 | CLASSIFYING TUMORS AND PREDICTING RESPONSIVENESS | INSIGHT MOLECULAR DIAGNOSTICS INC. | 2025-05-01 | — | — | US | disclosed |
| US-20240309418-A1 | ENZYMATIC METHODS AND COMPOSITIONS FOR POLYMERIZATION OF PHOSPHORAMIDATE AND THIOPHOSPHORAMIDATE-LINKED DNA | MASSACHUSETTS GEN HOSPITAL (US) | 2024-09-19 | — | — | US | disclosed |
| WO-2024192269-A2 | ENZYMATIC METHODS AND COMPOSITIONS FOR POLYMERIZATION OF PHOSPHORAMIDATE AND THIOPHOSPHORAMIDATE-LINKED DNA | THE GENERAL HOSPITAL CORPORATION (US) | 2024-09-19 | — | — | WO | disclosed |
| US-20220244263-A1 | METHODS FOR TREATING SMALL CELL NEUROENDOCRINE AND RELATED CANCERS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2022-08-04 | — | — | US | disclosed |
| US-20220087987-A1 | A METHOD FOR TREATING SWI/SNF COMPLEX-DEFICIENT CANCERS COMPRISING GLUTATHIONE (GSH) METABOLIC PATHWAY INHIBITOR | NATIONAL CANCER CENTER (JP) | 2022-03-24 | — | — | US | disclosed |
| EP-3971178-A1 | AMINOQUINOLINE DERIVATIVES AND USES THEREOF | The McLean Hospital Corporation (US) | 2022-03-23 | — | — | EP | disclosed |
| US-20220064656-A1 | GENE EXPRESSION ELEMENTS AND SYSTEMS AND USE THEREOF | GENENEER LTD. (IL) | 2022-03-03 | — | — | US | disclosed |
| US-7235695-B2 | Cycloalkyl substituted polyamines for cancer therapy and methods of synthesis therefor | SLIL BIOMEDICAL CORPORATION | 2007-06-26 | — | — | US | disclosed |
| US-7235695-B2 | Cycloalkyl substituted polyamines for cancer therapy and methods of synthesis therefor | SLIL BIOMEDICAL CORPORATION | 2007-06-26 | — | — | US | disclosed |
| US-6627399-B1 | Using compound of given formula as accelerator | RIKEN (JP) | 2003-09-30 | — | — | US | disclosed |
| US-6605645-B2 | Such as 1,15-di(cyclopropylmethylamino)-8-benzyl-4,8,12-triazapentadecane; carcinostatic action | RIKEN (JP) | 2003-08-12 | — | — | US | disclosed |
| US-20030073202-A1 | RNA polymerase transcription promoter and nucleic acid sequencing method | IWATA MASAAKI (JP) | 2003-04-17 | — | — | US | disclosed |
| US-20020067472-A1 | Linear polyamine compounds and polyamine anticancer agents | IWATA MASAAKI (JP) | 2002-06-06 | — | — | US | disclosed |
| US-6319956-B1 | N1, N4-BIS(CYCLOPROPYLMETHYLAMINO)TRIALKYLENETETRAMINES THAT MAY BE TOLUENESULFONATED. | RIKEN (JP) | 2001-11-20 | — | — | US | disclosed |
| EP-1061130-A1 | RNA POLYMERASE TRANSCRIPTION PROMOTERS AND METHOD FOR DETERMINING BASE SEQUENCE | Riken (JP) | 2000-12-20 | — | — | EP | disclosed |
| US-6114394-A | Polyamine derivatives as radioprotective agents | MERRELL PHARMACEUTICALS INC. (US) | 2000-09-05 | — | — | US | disclosed |
| JP-H08217670-A | AMELIORANT FOR CEREBRAL FUNCTION | MEIJI SEIKA KAISHA LTD | 1996-08-27 | — | — | JP | disclosed |